Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Platelet-rich Plasma Gel may help treat en coup de sabre scleroderma, improving symptoms and skin quality with minimal side effects.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

Ixekizumab effectively treats generalized pustular psoriasis.

Entospletinib effectively prevents eye and skin GVHD in mice.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Epiregulin can help hair grow and may be useful for treating hair loss.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Ritlecitinib is safe and may effectively treat alopecia areata.

Monoclonal antibodies are often linked to alopecia areata cases.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

A patient lost all their hair while on rheumatoid arthritis medication.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

A new method effectively predicts estrogen-related health effects for early screening.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Researchers found two new genetic variants linked to Alzheimer's disease.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.